PepsiCo released its 2023 third quarter fiscal year report and beat Wall Street estimates, citing increased demand for smaller-sized snacks and healthier options, as the company faces challenges from PRIME in the sports drink category and anticipates potential long-term impact on its business from Ozempic and other weight-loss drugs.
PepsiCo released its 2023 third quarter fiscal year report and beat Wall Street estimates, citing increased demand for smaller-sized snacks and healthier options, as the company faces challenges from PRIME in the sports drink category and anticipates potential long-term impact on its business from Ozempic and other weight-loss drugs.
PepsiCo released its 2023 third quarter fiscal year report and beat Wall Street estimates, citing increased demand for smaller-sized snacks and healthier options, as the company faces challenges from PRIME in the sports drink category and anticipates potential long-term impact on its business from Ozempic and other weight-loss drugs.